CLEC4G Reverses Lenvatinib Resistance in Hepatocellular Carcinoma by Suppressing PD‐1 Expression via the Wnt/β‐Catenin Pathway

Q: How does OCRA curate its research paper database?

OCRA indexes peer-reviewed papers from PubMed and CrossRef, enriched with MeSH terms, author profiles, and citation metrics. Papers are categorized by cancer type, research method, and clinical relevance.

Q: Can I search papers by MeSH term or author?

Yes. Use the search bar to filter papers by MeSH term, author name, journal, keyword, or cancer type. Each paper includes linked MeSH terms and author profiles for further exploration.

Q: How current is the paper database?

The database is updated regularly through automated ingestion from PubMed and CrossRef. Most papers appear within days of their PubMed indexing date.

doi:10.1155/ijog/9225945

CLEC4G Reverses Lenvatinib Resistance in Hepatocellular Carcinoma by Suppressing PD‐1 Expression via the Wnt/β‐Catenin Pathway

Kemin Xiao & Bin He et al. · 2025

Links

DOI

Journal

Unknown Journal

Authors

Kemin Xiao, Jin Yan, Guangxi He, Bin He